STOCK TITAN

iTeos Therapeutics, Inc. (ITOS) Revenue by Year

ITOS

iTeos Therapeutics, Inc. generated $35.0M in revenue in fiscal year 2024. This represents an increase of 177.9% from the prior fiscal year. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters iTeos Therapeutics, Inc. has filed alongside them.

FY2024 annual
Revenue $35.0M
YoY +177.9%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ITOS Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Revenue$35.0M+177.9%$12.6M-95.3%$267.6M-22.4%$344.8MN/AN/A

ITOS Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-Q
Revenue$0-100.0%N/AN/A$0$35.0M$0-100.0%N/A$0-100.0%$0-100.0%$12.6M-91.7%$53.9M$19.5M-81.3%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More iTeos Therapeutics, Inc. financials

Frequently Asked Questions

What was iTeos Therapeutics, Inc.'s revenue in fiscal year 2024?

iTeos Therapeutics, Inc. generated $35.0M in revenue in fiscal year 2024.

How fast is iTeos Therapeutics, Inc.'s revenue growing?

iTeos Therapeutics, Inc. (ITOS) revenue rose by 177.9% year over year, from $12.6M to $35.0M in fiscal year 2024.

What was iTeos Therapeutics, Inc.'s revenue in the most recent quarter?

iTeos Therapeutics, Inc. (ITOS) reported $0 in revenue in Q2 2025. This represents a decrease of 100.0% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what iTeos Therapeutics, Inc. (ITOS) reported on that line in every period on record.